Home > Insider Trading > Filing (0000899243-24-000121)

Filing Details

Accession Number:: 0000899243-24-000121
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-01-26 19:19:29
Reporting Period:: 2024-01-24

Accepted Time:: 2024-01-26 19:19:29
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1799191	Oncology Institute Inc.	TOI	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1705748	Havencrest Healthcare Partners, L.p.	2100 Mckinney Ave, Suite 1760 Dallas TX 75201	No	No	Yes	No
1892154	Toi Hc I, Llc	2100 Mckinney Ave, Suite 1760 Dallas TX 75201	No	No	Yes	No
1893722	Havencrest Healthcare Partners Gp, Llc	2100 Mckinney Ave, Suite 1760 Dallas TX 75201	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-01-24	24,915	$2.30	27,498	No	4	S	Indirect	See footnote
Common Stock	Disposition	2024-01-25	11,882	$2.07	15,616	No	4	S	Indirect	See footnote
Common Stock	Disposition	2024-01-26	6,979	$2.14	8,637	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	8,801,823	Indirect	See footnote

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.15 to $2.44, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.01 to $2.19, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.09 to $2.19, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
Havencrest Healthcare Partners GP, LLC (the "General Partner") is the record holder of these shares of the Issuer's common stock.
TOI HC I, LLC is the record holder of these 8,801,823 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. The General Partner controls Havencrest Healthcare Partners, L.P.